Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and Deferred Revenue

v2.4.0.6
Accrued Liabilities and Deferred Revenue
3 Months Ended
Mar. 31, 2012
Accrued Liabilities and Deferred Revenue [Abstract]  
ACCRUED LIABILITIES AND DEFERRED REVENUE

NOTE 7 – ACCRUED LIABILITIES AND DEFERRED REVENUE

Accrued liabilities are comprised of the following (in thousands):

 

                 
    March 31,
2012
    December 31,
2011
 

Payroll and benefits

  $ 1,645     $ 1,928  

Warranty accrual

    1,926       2,218  

Sales tax

    419       526  

Accrued professional services

    689       669  

Accrued insurance premium

    242       433  

Accrued support services

    350       200  

Other

    171       203  
   

 

 

   

 

 

 

Accrued liabilities

  $ 5,442     $ 6,177  
   

 

 

   

 

 

 

 

Changes in the initial product warranty accrual, and the expenses incurred under our initial and extended warranties, for the three months ended March 31, 2012 and 2011 were as follows (in thousands):

 

                 
    Three Months Ended
March 31,
 
    2012     2011  

Initial warranty accrual, beginning balance

  $ 2,218     $ 2,725  

Provision for estimated warranty cost

    122       508  

Warranty expenditures

    (414     (505
   

 

 

   

 

 

 

Initial warranty accrual, ending balance

    1,926       2,728  

Total warranty accrual, long term

    —         (524
   

 

 

   

 

 

 

Total warranty accrual, current portion

  $ 1,926     $ 2,204  
   

 

 

   

 

 

 

Deferred revenue is comprised of the following (in thousands):

 

                 
    March 31, 2012     December 31, 2011  

Undelivered elements (training, installation and product and support services)

  $ 1,171     $ 1,105  

Extended warranty contracts

    1,078       1,056  
   

 

 

   

 

 

 

Total deferred revenue

    2,249       2,161  
   

 

 

   

 

 

 

Less long-term amounts:

               

Extended warranty contracts

    (17     (25
   

 

 

   

 

 

 

Total deferred revenue, long-term

    (17     (25
   

 

 

   

 

 

 

Total deferred revenue, current portion

  $ 2,232     $ 2,136  
   

 

 

   

 

 

 

On May 20, 2010, the Company entered into a license agreement (the “2010 P&G Agreement”), with Procter and Gamble Company (“P&G”), which replaced an existing license agreement between the Company and P&G (the “2006 P&G Agreement”). Pursuant to the 2010 P&G Agreement, the Company agreed to continue granting P&G an exclusive license to certain of the Company’s patents to enable P&G to develop products aimed at the consumer market and P&G agreed to pay royalties based on sales of products developed with such intellectual property. On June 28, 2011, the Company entered into an amendment to the 2010 P&G Agreement (the “2011 P&G Amendment”) which extended the effective period for the 2010 P&G Agreement from December 31, 2010 through June 30, 2011, and resulted in the Company recognizing the previously deferred $375,000 of revenue as royalty revenue during the quarter ended June 30, 2011.

The 2011 P&G Amendment also provided that effective January 1, 2011, P&G’s exclusive license to the Company’s patents converted to a non-exclusive license unless P&G paid the Company a license payment in the amount of $187,500 by the end of the third quarter of 2011, and at the end of each quarter thereafter, throughout the term of the 2010 P&G Agreement. As a result of P&G not making any payments to the Company in the third and fourth quarters of the year ended December 31, 2011, their license converted to a non-exclusive license. The Company is currently engaged in an active collaboration with P&G to commercialize a consumer product utilizing its patents.